Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
528.65
Change Change %
3.55 0.68%

Updated:23 May, 2019, 14:44 PM IST

BSE
525.25
Change Change %
0.85 0.16%

Updated:23 May, 2019, 15:21 PM IST

Alembic Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18 MAR'17
Operational & Financial Ratios:
   Earnings Per Share (Rs) 22.39 22.85
   DPS(Rs) 4.00 4.00
   Book NAV/Share(Rs) 116.43 99.06
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 13.64 18.36
   ROE(%) 20.78 25.35
   ROCE(%) 22.91 32.46
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 24.56 27.30
   PCE(x) 19.79 22.89
   Price / Book(x) 4.72 6.30
   Yield(%) 0.73 0.64
   EV / Net Sales(x) 3.72 3.94
   EV / Core EBITDA(x) 17.16 18.49
   EV / EBIT(x) 20.41 21.26
   EV / CE(x) 2.98 4.69
   M Cap / Sales 3.52 3.94
Growth Ratio:
   Core Operating Income Growth -30.84 -12.77
   Operating Profit Growth 0.53 -35.75
   Net Profit Growth -2.01 -38.37
   BVPS Growth 17.53 21.99
   Advances Growth 0.00 0.00
   EPS Growth(%) -2.01 -38.37
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top